Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Displaying 3 studies
The purpose of this study is to evaluate the effectiveness and safety of oral PRN1008 in moderate to severe pemphigus.
The primary purpose of this study is to assess the safety of extended treatment and retreatment with efgartigimod PH20 SC in patients with Pemphigus Vulgaris (PV) or Pemphigus Foliaceus (PF).
The primary purpose of this study is to demonstrate the effectiveness of efgartigimod PH20 SC compared to placebo in the treatment of patients with Pemphigus Vulgaris (PV).